The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria
Abstract
To cite this article: Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, Hide M. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010; 65 : 649–656. Background: The evaluation of disease severity and activity of chronic urticaria (CU) is essential for the adequate treatment of patients. However, there is no reliable biomarker for such evaluations. Recently, markers of blood coagulation and fibrinolysis have been revealed to be elevated in severe cases of CU. In this article, we studied the coagulation/fibrinolysis and inflammation markers and their relationship to disease activity in patients with CU. Methods: Plasma fibrin degradation products (FDP), d‐ dimer and serum C‐reactive protein (CRP) were measured with the assessment of disease severity and skin reaction to autologous serum in 82 patients with CU and 37 patients with acute urticaria, idiopathic angioedema (AE) or inducible types of urticaria (IU). Results: The levels of FDP in patients with CU were significantly higher than those in patients with IU, but no other differences in FDP, d‐ dimer and CRP were observed among patients with different types of urticaria. These markers of patients with CU were well correlated with each other and significantly associated with disease severity of CU, but not with skin reactions to autologous serum. In 37 patients with CU, levels of all these parameters reduced as their disease condition improved, while they increased when the disease became aggravated. Regarding FDP, this relationship was observed even if FDP concentrations were within normal range throughout the study. Conclusions: The measurement of plasma FDP, d‐ dimer and serum CRP may be useful for the assessment of disease activity of CU.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How to assess disease activity in patients with chronic urticaria?
Młynek, A., Zalewska‐Janowska, A., Martus, P., Staubach, P., Zuberbier, T., & Maurer, M. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01726.x · Cited by 385
Cited by
The diagnosis and management of acute and chronic urticaria: 2014 update
Bernstein, J. A., Lang, D. M., Khan, D. A., Craig, T., Dreyfus, D., Hsieh, F., Sheikh, J., Weldon, D., Zuraw, B., Bernstein, D. I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.036 · Cited by 682
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S. (2017) · Allergy · doi:10.1111/all.13083 · Cited by 293
Metadata
- Authors
- Takahagi, S., Mihara, S., Iwamoto, K., Morioke, S., Okabe, T., Kameyoshi, Y., & Hide, M.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2010-04
- Volume
- 65
- Issue
- 5
- Pages
- 649-656
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1981404520
- Cited by
- 171
- References
- 1
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. https://app.cochat.ai/papers/10.1111/j.1398-9995.2009.02222.x
- The paper
- Takahagi, S., Mihara, S., Iwamoto, K., Morioke, S., Okabe, T., Kameyoshi, Y., & Hide, M. (2010). Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. https://doi.org/10.1111/j.1398-9995.2009.02222.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.